1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Cognitive and Memory Enhancer Drugs Market Size 2019-2030 2.1.2 Cognitive and Memory Enhancer Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Cognitive and Memory Enhancer Drugs Segment by Type 2.2.1 Aricept 2.2.2 Exelon 2.2.3 Namenda 2.2.4 Razadyne 2.2.5 Provigil 2.2.6 Ritalin 2.2.7 Adderall 2.2.8 Others 2.3 Cognitive and Memory Enhancer Drugs Market Size by Type 2.3.1 Cognitive and Memory Enhancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) 2.4 Cognitive and Memory Enhancer Drugs Segment by Application 2.4.1 Disease Treatment 2.4.2 Academic Performance 2.4.3 Athletic Performance 2.4.4 Others 2.5 Cognitive and Memory Enhancer Drugs Market Size by Application 2.5.1 Cognitive and Memory Enhancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) 3 Cognitive and Memory Enhancer Drugs Market Size by Player 3.1 Cognitive and Memory Enhancer Drugs Market Size Market Share by Players 3.1.1 Global Cognitive and Memory Enhancer Drugs Revenue by Players (2019-2024) 3.1.2 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Players (2019-2024) 3.2 Global Cognitive and Memory Enhancer Drugs Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Cognitive and Memory Enhancer Drugs by Regions 4.1 Cognitive and Memory Enhancer Drugs Market Size by Regions (2019-2024) 4.2 Americas Cognitive and Memory Enhancer Drugs Market Size Growth (2019-2024) 4.3 APAC Cognitive and Memory Enhancer Drugs Market Size Growth (2019-2024) 4.4 Europe Cognitive and Memory Enhancer Drugs Market Size Growth (2019-2024) 4.5 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Growth (2019-2024) 5 Americas 5.1 Americas Cognitive and Memory Enhancer Drugs Market Size by Country (2019-2024) 5.2 Americas Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) 5.3 Americas Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Cognitive and Memory Enhancer Drugs Market Size by Region (2019-2024) 6.2 APAC Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) 6.3 APAC Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Cognitive and Memory Enhancer Drugs by Country (2019-2024) 7.2 Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) 7.3 Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Cognitive and Memory Enhancer Drugs by Region (2019-2024) 8.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) 8.3 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Cognitive and Memory Enhancer Drugs Market Forecast 10.1 Global Cognitive and Memory Enhancer Drugs Forecast by Regions (2025-2030) 10.1.1 Global Cognitive and Memory Enhancer Drugs Forecast by Regions (2025-2030) 10.1.2 Americas Cognitive and Memory Enhancer Drugs Forecast 10.1.3 APAC Cognitive and Memory Enhancer Drugs Forecast 10.1.4 Europe Cognitive and Memory Enhancer Drugs Forecast 10.1.5 Middle East & Africa Cognitive and Memory Enhancer Drugs Forecast 10.2 Americas Cognitive and Memory Enhancer Drugs Forecast by Country (2025-2030) 10.2.1 United States Cognitive and Memory Enhancer Drugs Market Forecast 10.2.2 Canada Cognitive and Memory Enhancer Drugs Market Forecast 10.2.3 Mexico Cognitive and Memory Enhancer Drugs Market Forecast 10.2.4 Brazil Cognitive and Memory Enhancer Drugs Market Forecast 10.3 APAC Cognitive and Memory Enhancer Drugs Forecast by Region (2025-2030) 10.3.1 China Cognitive and Memory Enhancer Drugs Market Forecast 10.3.2 Japan Cognitive and Memory Enhancer Drugs Market Forecast 10.3.3 Korea Cognitive and Memory Enhancer Drugs Market Forecast 10.3.4 Southeast Asia Cognitive and Memory Enhancer Drugs Market Forecast 10.3.5 India Cognitive and Memory Enhancer Drugs Market Forecast 10.3.6 Australia Cognitive and Memory Enhancer Drugs Market Forecast 10.4 Europe Cognitive and Memory Enhancer Drugs Forecast by Country (2025-2030) 10.4.1 Germany Cognitive and Memory Enhancer Drugs Market Forecast 10.4.2 France Cognitive and Memory Enhancer Drugs Market Forecast 10.4.3 UK Cognitive and Memory Enhancer Drugs Market Forecast 10.4.4 Italy Cognitive and Memory Enhancer Drugs Market Forecast 10.4.5 Russia Cognitive and Memory Enhancer Drugs Market Forecast 10.5 Middle East & Africa Cognitive and Memory Enhancer Drugs Forecast by Region (2025-2030) 10.5.1 Egypt Cognitive and Memory Enhancer Drugs Market Forecast 10.5.2 South Africa Cognitive and Memory Enhancer Drugs Market Forecast 10.5.3 Israel Cognitive and Memory Enhancer Drugs Market Forecast 10.5.4 Turkey Cognitive and Memory Enhancer Drugs Market Forecast 10.5.5 GCC Countries Cognitive and Memory Enhancer Drugs Market Forecast 10.6 Global Cognitive and Memory Enhancer Drugs Forecast by Type (2025-2030) 10.7 Global Cognitive and Memory Enhancer Drugs Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Pfizer 11.1.1 Pfizer Company Information 11.1.2 Pfizer Cognitive and Memory Enhancer Drugs Product Offered 11.1.3 Pfizer Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Pfizer Main Business Overview 11.1.5 Pfizer Latest Developments 11.2 Eisai Co 11.2.1 Eisai Co Company Information 11.2.2 Eisai Co Cognitive and Memory Enhancer Drugs Product Offered 11.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Eisai Co Main Business Overview 11.2.5 Eisai Co Latest Developments 11.3 Allergan 11.3.1 Allergan Company Information 11.3.2 Allergan Cognitive and Memory Enhancer Drugs Product Offered 11.3.3 Allergan Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Allergan Main Business Overview 11.3.5 Allergan Latest Developments 11.4 Novartis 11.4.1 Novartis Company Information 11.4.2 Novartis Cognitive and Memory Enhancer Drugs Product Offered 11.4.3 Novartis Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Novartis Main Business Overview 11.4.5 Novartis Latest Developments 11.5 Takeda 11.5.1 Takeda Company Information 11.5.2 Takeda Cognitive and Memory Enhancer Drugs Product Offered 11.5.3 Takeda Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Takeda Main Business Overview 11.5.5 Takeda Latest Developments 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Information 11.6.2 Johnson & Johnson Cognitive and Memory Enhancer Drugs Product Offered 11.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Johnson & Johnson Main Business Overview 11.6.5 Johnson & Johnson Latest Developments 11.7 Takeda Pharmaceutical Company Limited 11.7.1 Takeda Pharmaceutical Company Limited Company Information 11.7.2 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Product Offered 11.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Takeda Pharmaceutical Company Limited Main Business Overview 11.7.5 Takeda Pharmaceutical Company Limited Latest Developments 11.8 AlternaScript 11.8.1 AlternaScript Company Information 11.8.2 AlternaScript Cognitive and Memory Enhancer Drugs Product Offered 11.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 AlternaScript Main Business Overview 11.8.5 AlternaScript Latest Developments 11.9 Cephalon 11.9.1 Cephalon Company Information 11.9.2 Cephalon Cognitive and Memory Enhancer Drugs Product Offered 11.9.3 Cephalon Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Cephalon Main Business Overview 11.9.5 Cephalon Latest Developments 11.10 Ceretropic 11.10.1 Ceretropic Company Information 11.10.2 Ceretropic Cognitive and Memory Enhancer Drugs Product Offered 11.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Ceretropic Main Business Overview 11.10.5 Ceretropic Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Cognitive and Memory Enhancer Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions) Table 2. Major Players of Aricept Table 3. Major Players of Exelon Table 4. Major Players of Namenda Table 5. Major Players of Razadyne Table 6. Major Players of Provigil Table 7. Major Players of Ritalin Table 8. Major Players of Adderall Table 9. Major Players of Others Table 10. Cognitive and Memory Enhancer Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions) Table 11. Global Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) & ($ Millions) Table 12. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Table 13. Cognitive and Memory Enhancer Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions) Table 14. Global Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) & ($ Millions) Table 15. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Table 16. Global Cognitive and Memory Enhancer Drugs Revenue by Players (2019-2024) & ($ Millions) Table 17. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Player (2019-2024) Table 18. Cognitive and Memory Enhancer Drugs Key Players Head office and Products Offered Table 19. Cognitive and Memory Enhancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 20. New Products and Potential Entrants Table 21. Mergers & Acquisitions, Expansion Table 22. Global Cognitive and Memory Enhancer Drugs Market Size by Regions 2019-2024 & ($ Millions) Table 23. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Regions (2019-2024) Table 24. Global Cognitive and Memory Enhancer Drugs Revenue by Country/Region (2019-2024) & ($ millions) Table 25. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Country/Region (2019-2024) Table 26. Americas Cognitive and Memory Enhancer Drugs Market Size by Country (2019-2024) & ($ Millions) Table 27. Americas Cognitive and Memory Enhancer Drugs Market Size Market Share by Country (2019-2024) Table 28. Americas Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) & ($ Millions) Table 29. Americas Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Table 30. Americas Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) & ($ Millions) Table 31. Americas Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Table 32. APAC Cognitive and Memory Enhancer Drugs Market Size by Region (2019-2024) & ($ Millions) Table 33. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Region (2019-2024) Table 34. APAC Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) & ($ Millions) Table 35. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Table 36. APAC Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) & ($ Millions) Table 37. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Table 38. Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2019-2024) & ($ Millions) Table 39. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Country (2019-2024) Table 40. Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) & ($ Millions) Table 41. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Table 42. Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) & ($ Millions) Table 43. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Table 44. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Region (2019-2024) & ($ Millions) Table 45. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Region (2019-2024) Table 46. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2019-2024) & ($ Millions) Table 47. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Table 48. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2019-2024) & ($ Millions) Table 49. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Table 50. Key Market Drivers & Growth Opportunities of Cognitive and Memory Enhancer Drugs Table 51. Key Market Challenges & Risks of Cognitive and Memory Enhancer Drugs Table 52. Key Industry Trends of Cognitive and Memory Enhancer Drugs Table 53. Global Cognitive and Memory Enhancer Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions) Table 54. Global Cognitive and Memory Enhancer Drugs Market Size Market Share Forecast by Regions (2025-2030) Table 55. Global Cognitive and Memory Enhancer Drugs Market Size Forecast by Type (2025-2030) & ($ Millions) Table 56. Global Cognitive and Memory Enhancer Drugs Market Size Forecast by Application (2025-2030) & ($ Millions) Table 57. Pfizer Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 58. Pfizer Cognitive and Memory Enhancer Drugs Product Offered Table 59. Pfizer Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 60. Pfizer Main Business Table 61. Pfizer Latest Developments Table 62. Eisai Co Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 63. Eisai Co Cognitive and Memory Enhancer Drugs Product Offered Table 64. Eisai Co Main Business Table 65. Eisai Co Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 66. Eisai Co Latest Developments Table 67. Allergan Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 68. Allergan Cognitive and Memory Enhancer Drugs Product Offered Table 69. Allergan Main Business Table 70. Allergan Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 71. Allergan Latest Developments Table 72. Novartis Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 73. Novartis Cognitive and Memory Enhancer Drugs Product Offered Table 74. Novartis Main Business Table 75. Novartis Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 76. Novartis Latest Developments Table 77. Takeda Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 78. Takeda Cognitive and Memory Enhancer Drugs Product Offered Table 79. Takeda Main Business Table 80. Takeda Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 81. Takeda Latest Developments Table 82. Johnson & Johnson Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 83. Johnson & Johnson Cognitive and Memory Enhancer Drugs Product Offered Table 84. Johnson & Johnson Main Business Table 85. Johnson & Johnson Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 86. Johnson & Johnson Latest Developments Table 87. Takeda Pharmaceutical Company Limited Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 88. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Product Offered Table 89. Takeda Pharmaceutical Company Limited Main Business Table 90. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 91. Takeda Pharmaceutical Company Limited Latest Developments Table 92. AlternaScript Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 93. AlternaScript Cognitive and Memory Enhancer Drugs Product Offered Table 94. AlternaScript Main Business Table 95. AlternaScript Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 96. AlternaScript Latest Developments Table 97. Cephalon Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 98. Cephalon Cognitive and Memory Enhancer Drugs Product Offered Table 99. Cephalon Main Business Table 100. Cephalon Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 101. Cephalon Latest Developments Table 102. Ceretropic Details, Company Type, Cognitive and Memory Enhancer Drugs Area Served and Its Competitors Table 103. Ceretropic Cognitive and Memory Enhancer Drugs Product Offered Table 104. Ceretropic Main Business Table 105. Ceretropic Cognitive and Memory Enhancer Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 106. Ceretropic Latest Developments List of Figures Figure 1. Cognitive and Memory Enhancer Drugs Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate 2019-2030 ($ Millions) Figure 6. Cognitive and Memory Enhancer Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Cognitive and Memory Enhancer Drugs Sales Market Share by Country/Region (2023) Figure 8. Cognitive and Memory Enhancer Drugs Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Type in 2023 Figure 10. Cognitive and Memory Enhancer Drugs in Disease Treatment Figure 11. Global Cognitive and Memory Enhancer Drugs Market: Disease Treatment (2019-2024) & ($ Millions) Figure 12. Cognitive and Memory Enhancer Drugs in Academic Performance Figure 13. Global Cognitive and Memory Enhancer Drugs Market: Academic Performance (2019-2024) & ($ Millions) Figure 14. Cognitive and Memory Enhancer Drugs in Athletic Performance Figure 15. Global Cognitive and Memory Enhancer Drugs Market: Athletic Performance (2019-2024) & ($ Millions) Figure 16. Cognitive and Memory Enhancer Drugs in Others Figure 17. Global Cognitive and Memory Enhancer Drugs Market: Others (2019-2024) & ($ Millions) Figure 18. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Application in 2023 Figure 19. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Player in 2023 Figure 20. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Regions (2019-2024) Figure 21. Americas Cognitive and Memory Enhancer Drugs Market Size 2019-2024 ($ Millions) Figure 22. APAC Cognitive and Memory Enhancer Drugs Market Size 2019-2024 ($ Millions) Figure 23. Europe Cognitive and Memory Enhancer Drugs Market Size 2019-2024 ($ Millions) Figure 24. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2019-2024 ($ Millions) Figure 25. Americas Cognitive and Memory Enhancer Drugs Value Market Share by Country in 2023 Figure 26. United States Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 27. Canada Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 28. Mexico Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 29. Brazil Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 30. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Region in 2023 Figure 31. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Type in 2023 Figure 32. APAC Cognitive and Memory Enhancer Drugs Market Size Market Share by Application in 2023 Figure 33. China Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 34. Japan Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 35. Korea Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 36. Southeast Asia Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 37. India Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 38. Australia Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 39. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Country in 2023 Figure 40. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Figure 41. Europe Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Figure 42. Germany Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 43. France Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 44. UK Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 45. Italy Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 46. Russia Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 47. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Region (2019-2024) Figure 48. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Type (2019-2024) Figure 49. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size Market Share by Application (2019-2024) Figure 50. Egypt Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 51. South Africa Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 52. Israel Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 53. Turkey Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 54. GCC Country Cognitive and Memory Enhancer Drugs Market Size Growth 2019-2024 ($ Millions) Figure 55. Americas Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 56. APAC Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 57. Europe Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 58. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 59. United States Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 60. Canada Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 61. Mexico Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 62. Brazil Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 63. China Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 64. Japan Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 65. Korea Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 66. Southeast Asia Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 67. India Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 68. Australia Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 69. Germany Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 70. France Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 71. UK Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 72. Italy Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 73. Russia Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 74. Spain Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 75. Egypt Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 76. South Africa Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 77. Israel Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 78. Turkey Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 79. GCC Countries Cognitive and Memory Enhancer Drugs Market Size 2025-2030 ($ Millions) Figure 80. Global Cognitive and Memory Enhancer Drugs Market Size Market Share Forecast by Type (2025-2030) Figure 81. Global Cognitive and Memory Enhancer Drugs Market Size Market Share Forecast by Application (2025-2030)